Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/41477
Tipo: Artigo de Periódico
Título: Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy
Autor(es): Denise Mayumi Tanaka
Luciano Fonseca Lemos de Oliveira
José Antonio Marin Neto
Minna Moreira Dias Romano
Eduardo Elias Vieira de Carvalho
Antonio Carlos Leite de Barros Filho
Fernando Fonseca França Ribeiro
Jorge Mejia Cabeza
Carla Duque Lopes
Camila Godoy Fabricio
Norival Kesper
Henrique Turin Moreira
Lauro Wichert Ana
André Schmidt
Maria de Lourdes Higuchi
Edecio Cunha Neto
Marcus Vinícius Simões
Resumen: Background: Myocardial perfusion defects (MPD) due to coronary microvascular dysfunction is frequent in chronic Chagas cardiomyopathy (CCC) and may be involved with development of myocardial damage. We investigated whether MPD precedes left ventricular systolic dysfunction and tested the hypothesis that prolonged use of dipyridamole (DIPY) could reduce MPD in an experimental model of CCC in hamsters. Methods and results: We investigated female hamsters 6-months after T. cruzi infection (baseline condition) and control animals, divided into T. cruzi-infected animals treated with DIPY (CH + DIPY) or placebo (CH + PLB); and uninfected animals treated with DIPY (CO + DIPY) or placebo (CO + PLB). The animals were submitted to echocardiogram and rest SPECT-Sestamibi-Tc99m myocardial perfusion scintigraphy. Next, the animals were treated with DIPY (4 mg/kg bid, intraperitoneal) or saline for 30 days, and reevaluated with the same imaging methods. At baseline, the CH + PLB and CH + DIPY groups showed larger areas of perfusion defect (13.2 ± 13.2% and 17.3 ± 13.2%, respectively) compared with CO + PLB and CO + DIPY (3.8 ± 2.2% e 3.5 ± 2.7%, respectively), P < .05. After treatment, we observed: reduction of perfusion defects only in the CH + DIPY group (17.3 ± 13.2% to 6.8 ± 7.6%, P = .001) and reduction of LVEF in CH + DIPY and CH + PLB groups (from 65.3 ± 9.0% to 53.6 ± 6.9% and from 69.3 ± 5.0% to 54.4 ± 8.6%, respectively, P < .001). Quantitative histology revealed greater extents of inflammation and interstitial fibrosis in both Chagas groups, compared with control group (P < .001), but no difference between Chagas groups (P > .05). Conclusions: The prolonged use of DIPY in this experimental model of CCC has reduced the rest myocardial perfusion defects, supporting the notion that those areas correspond to viable hypoperfused myocardium.
Asunto: Cardiomiopatia chagásica
Microcirculação
Circulação coronária
Animais de laboratório
Disfunção ventricular
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Institución: UFMG
Departamento: EEF - DEPARTAMENTO DE FISIOTERAPIA
Tipo de acceso: Acesso Restrito
Identificador DOI: https://doi.org/10.1007/s12350-018-1198-7
URI: http://hdl.handle.net/1843/41477
Fecha del documento: sep-2019
metadata.dc.url.externa: https://link.springer.com/article/10.1007/s12350-018-1198-7
metadata.dc.relation.ispartof: Journal of Nuclear Cardiology
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
no existem archivos asociados a este elemento.


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.